Danaher Corporation (DHR) reported that it outperformed its 4th Quarter ending December 31, 2022. Earnings per share came to $2.87 versus his $2.55 forecast.
Reported revenue of $8.37 billion represents 9.21% growth compared to the previous quarter and 2.71% growth compared to the same period last year.
for onest For the quarter, analysts are projecting earnings of $2.44 per share.
Earnings announcements often affect stock prices.see the history of Revenue-related price fluctuations For DHR stock.
What’s Next After Danaher Corporation’s Earnings?
According to TipRanks, the average analyst consensus for DHR stock is a moderate buy. This consensus is based on his seven analyst assessments over the past three months.Danaher Corporation average price target $298.57 means a 9.94% increase from the current level.
see us earnings calendar For a complete list of this week’s earnings releases.
Conclusion
Earnings growth may indicate a positive move in the stock price. DHR is currently priced at $271.58, showing an increase of 0.30% in 5 days.
About Danaher Corporation
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. manufactures, designs, and markets professional, medical, industrial, and commercial products and services. The company operates in three segments including Life Sciences, Diagnostics, Environmental and Applied Solutions.
Learn more about DHR finances here